Sökning: onr:"swepub:oai:DiVA.org:oru-98903" >
The European respon...
The European response to control and manage multi- and extensively drug-resistant Neisseria gonorrhoeae
-
- Cole, Michelle J. (författare)
- UK Health Security Agency, London, United Kingdom
-
- Day, Michaela (författare)
- UK Health Security Agency, London, United Kingdom
-
- Jacobsson, Susanne, 1974- (författare)
- Örebro universitet,Institutionen för medicinska vetenskaper,Region Örebro län,World Health Organization Collaborating Centre for Gonorrhoea and other STIs
-
visa fler...
-
- Amato-Gauci, Andrew J. (författare)
- European Centre for Disease Prevention and Control, Stockholm, Sweden
-
- Spiteri, Gianfranco (författare)
- European Centre for Disease Prevention and Control, Stockholm, Sweden
-
- Unemo, Magnus, 1970- (författare)
- Örebro universitet,Institutionen för medicinska vetenskaper,Region Örebro län,University College London (UCL), London, United Kingdom; World Health Organization Collaborating Centre for Gonorrhoea and other STIs, Örebro University, Örebro, Sweden
-
European Gonorrhoea Response Plan Group, - (bidragsgivare)
-
visa färre...
-
(creator_code:org_t)
- European Centre for Disease Prevention and Control, 2022
- 2022
- Engelska.
-
Ingår i: Eurosurveillance. - : European Centre for Disease Prevention and Control. - 1025-496X .- 1560-7917. ; 27:18, s. 37-43
- Relaterad länk:
-
https://doi.org/10.2...
-
visa fler...
-
https://urn.kb.se/re...
-
https://doi.org/10.2...
-
visa färre...
Abstract
Ämnesord
Stäng
- Because cefixime and ceftriaxone resistance in Neisseria gonorrhoeae and gonorrhoea treatment failures were increasing, a response plan to control and manage multidrug-resistant N. gonorrhoeae (MDR-NG) in Europe was published in 2012. The three main areas of the plan were to: (i) strengthen surveillance of antimicrobial resistance (AMR), (ii) implement monitoring of treatment failures and (iii) establish a communication strategy to increase awareness and disseminate AMR results. Since 2012, several additional extensively drug-resistant N. gonorrhoeae (XDR-NG) strains have emerged, and strains with high-level ceftriaxone resistance spread internationally. This prompted an evaluation and review of the 2012 European Centre for Disease Prevention and Control (ECDC) response plan, revealing an overall improvement in many aspects of monitoring AMR in N. gonorrhoeae; however, treatment failure monitoring was a weakness. Accordingly, the plan was updated in 2019 to further support European Union/European Economic Area (EU/EEA) countries in controlling and managing the threat of MDR/XDR-NG in Europe through further strengthening of AMR surveillance and clinical management including treatment failure monitoring. The plan will be assessed biennially to ensure its effectiveness and its value. Along with prevention, diagnostic, treatment and epidemiological surveillance strategies, AMR surveillance is essential for effective control of gonorrhoea.
Ämnesord
- MEDICIN OCH HÄLSOVETENSKAP -- Klinisk medicin -- Infektionsmedicin (hsv//swe)
- MEDICAL AND HEALTH SCIENCES -- Clinical Medicine -- Infectious Medicine (hsv//eng)
Nyckelord
- EU/EEA
- MDR-NG
- XDR-NG
- antimicrobial resistance
- cephalosporins
- gonorrhoea
- surveillance
- treatment failure
Publikations- och innehållstyp
- ref (ämneskategori)
- art (ämneskategori)
Hitta via bibliotek
Till lärosätets databas